» Articles » PMID: 31887710

Inhibition Deficits Are Modulated by Age and CGG Repeat Length in Carriers of the FMR1 Premutation Allele Who Are Mothers of Children with Fragile X Syndrome

Overview
Journal Brain Cogn
Specialties Neurology
Psychiatry
Date 2019 Dec 31
PMID 31887710
Citations 22
Authors
Affiliations
Soon will be listed here.
Abstract

Individuals who carry a premutation (PM) allele on the FMR1 gene may experience executive limitations associated with their genetic status, including inhibition deficits. However, poor understanding of individualized risk factors has limited clinical management of this group, particularly in mothers who carry the PM allele who have children with fragile X syndrome (FXS). The present study examined CGG repeat length and age as factors that may account for variable expressivity of inhibition deficits. Participants were 134 carriers of the PM allele who were mothers of children with FXS. Inhibition skills were measured using both self-report and direct behavioral assessments. Increased vulnerability for inhibition deficits was observed at mid-range CGG lengths of approximately 80-100 repeats, with some evidence of a second zone of vulnerability occurring at approximately 130-140 CGG repeats. Risk associated with the genotype also became more pronounced with older age. This study identifies personalized risk factors that may be used to tailor the clinical management of executive deficits in carriers of the PM allele. Inhibition deficits may contribute to poor outcomes in carriers of the PM allele and their families, particularly in midlife and early old age, and clinical monitoring may be warranted.

Citing Articles

Reduced Respiratory Sinus Arrhythmia in Infants with the Premutation.

Chase A, Hamrick L, Arnold H, Smith J, Hantman R, Cortez K Int J Mol Sci. 2025; 26(5).

PMID: 40076819 PMC: 11900448. DOI: 10.3390/ijms26052186.


Sensorimotor and inhibitory control in aging premutation carriers.

Fielding-Gebhardt H, Kelly S, Unruh K, Schmitt L, Pulver S, Khemani P Front Hum Neurosci. 2023; 17:1271158.

PMID: 38034068 PMC: 10687573. DOI: 10.3389/fnhum.2023.1271158.


Insight and Recommendations for Fragile X-Premutation-Associated Conditions from the Fifth International Conference on Premutation.

Tassone F, Protic D, Allen E, Archibald A, Baud A, Brown T Cells. 2023; 12(18).

PMID: 37759552 PMC: 10529056. DOI: 10.3390/cells12182330.


Mortality in Women across the CGG Repeat Range: The Neuroprotective Effect of Higher Education.

Hong J, Dembo R, DaWalt L, Baker M, Berry-Kravis E, Mailick M Cells. 2023; 12(17).

PMID: 37681869 PMC: 10486613. DOI: 10.3390/cells12172137.


Activation Ratio Correlates with IQ in Female Carriers of the Premutation.

Protic D, Polli R, Hwang Y, Mendoza G, Hagerman R, Durbin-Johnson B Cells. 2023; 12(13).

PMID: 37443745 PMC: 10341054. DOI: 10.3390/cells12131711.


References
1.
Lekovich J, Man L, Xu K, Canon C, Lilienthal D, Stewart J . CGG repeat length and AGG interruptions as indicators of fragile X-associated diminished ovarian reserve. Genet Med. 2017; 20(9):957-964. DOI: 10.1038/gim.2017.220. View

2.
Raz N . The cognitive correlates of white matter abnormalities in normal aging: a quantitative review. Neuropsychology. 2000; 14(2):224-32. DOI: 10.1037//0894-4105.14.2.224. View

3.
Meza J, Owens E, Hinshaw S . Response Inhibition, Peer Preference and Victimization, and Self-Harm: Longitudinal Associations in Young Adult Women with and without ADHD. J Abnorm Child Psychol. 2015; 44(2):323-34. PMC: 4654696. DOI: 10.1007/s10802-015-0036-5. View

4.
Roberts J, Bailey Jr D, Mankowski J, Ford A, Sideris J, Weisenfeld L . Mood and anxiety disorders in females with the FMR1 premutation. Am J Med Genet B Neuropsychiatr Genet. 2008; 150B(1):130-9. DOI: 10.1002/ajmg.b.30786. View

5.
Yang J, Simon C, Niu Y, Bogost M, Schneider A, Tassone F . Phenotypes of hypofrontality in older female fragile X premutation carriers. Ann Neurol. 2013; 74(2):275-83. PMC: 3906211. DOI: 10.1002/ana.23933. View